Eternal Technologies Group, Inc. Announced Today Its Preliminary Outlook for the Year-Ending December 31, 2005.

HOUSTON -- For the year-ending December 31, 2005, Eternal Technologies Group, Inc. (OTCBB:ETLT) anticipates revenues in excess of $21,000,000. This compares with revenues of $16,834,759 for the year-ended December 31, 2004. The current period will benefit from the inclusion of the financial result of E-Sea Biomedical Engineering Co. International Ltd. which will be profitable for the fourth quarter. However, the fourth quarter will not reflect any material results from the Human dairy project as most of the revenue producing activity will begin in the first quarter of 2006. The company expects earnings for the year-ending December 31, 2005 to exceed those for the year-ended December 31, 2004. The company also anticipates a significant increase in net assets from those reported as of December 31, 2004.

About Eternal Technologies

Eternal is a major agricultural genetics and biopharmaceutical R&D firm operating in China with the support of the Chinese Government. Eternal's animal breeding division has a strong asset base, cash position and net income. Eternal has become one of China's leading institutions for biopharmaceutical and biotech research, pure breed cultivation and breed stock production. The Company has secured a key market niche by commercializing gene engineering technologies and providing superior breeding stock, allowing China's citizens the ability to improve their living standards. With the world's largest population, a double-digit national growth rate and entry into the WTO, Eternal Technologies has a playing field set for tremendous opportunity. As a prominent player in the agricultural genetics industry, cash in the bank and an untapped market, Eternal has the potential to become a major player in China's national growth.

For more information please visit website: www.eternaltechs.com

The following constitutes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Statements containing the words of phrases "will likely result," "are expected to," "will continue," "is anticipated," "estimates," "projects," "believes," "expects," "anticipates," "intends," "target," "goal," "plans," "objective," "should" or similar expressions identify forward-looking statements, which may appear in documents, reports, filings with the Securities and Exchange Commission, including this Annual Report on form 10-K, news releases, written or oral presentations made by officers or other representatives made by us to analysts, shareholders, investors, new organizations and others and discussions with management and other representatives of us. For such statements, we claim the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995.